Selected News
Chris Shumway Invests in PLL
Premier Lacrosse League, June 30, 2026
The Premier Lacrosse League (PLL) today announced the closing of a $100 million Series E financing round led by Ares and Joe Tsai, representing the largest capital raise in the history of professional lacrosse.
UVA McIntire School Cuts Ribbon for Shumway Hall
UVA Today, April 29, 2025
Chris Shumway, a 1988 McIntire School alumnus and founder of Shumway Capital, serves as a visiting scholar at his alma mater, with an emphasis on global macro investing. “McIntire has a long history of combining academic excellence and entrepreneurial spirit while always looking to what’s next and staying true to its core values,” Shumway said. “It was a great challenge to create a building for the future that fits into the core tradition and values that are UVA and I hope you will agree that the team nailed it.”
Centennial Reflections: The Impactful Learning Legacy of John Griffin (McIntire ’85) and Chris Shumway (McIntire ’88)
McIntire News, August 27, 2021
McIntire alumni John Griffin and Chris Shumway are well-known investors and Visiting Scholars who have driven important positive change within UVA, the Commerce School—and the lives of students. In their own way, each has played an important role in helping create a multitude of opportunities for students by sharing the wealth of knowledge they’ve accrued in their remarkable careers in finance.
Chris Shumway Donates $25M to Harvard to create Biotechnology MBA
Bloomberg, October 20, 2020
Former Tiger Cub Chris Shumway is helping Harvard University prepare a new breed of MBAs, equally at ease on Wall Street and in the laboratory. With a $25 million gift, Shumway and wife Carrie are supporting the joint life sciences MS/MBA program at Harvard Business School that took its first 11 students in August.
New SPAC Founded By Chris Shumway, John Collins, and Eric Grubman Raises $400M In IPO
SportsPro, September 15, 2020
Eric Grubman and John Collins have formed a special purpose acquisition company (SPAC) targeting the sports and entertainment sectors. Sports Entertainment Acquisition Corp, which also counts US investor Chris Shumway as a co-founder, filed with the securities and exchange commission (SEC) on 14th September for an initial public offering (IPO) it hopes will raise as much as US$350 million.
Shumway Capital Participates in Finch Therapeutics’s $90M Financing
Business Wire, September 17, 2020
Finch Therapeutics Group, Inc. (“Finch”), a clinical-stage microbiome drug development company, announced today a $90 million Series D financing. New investors in the round include Baupost Group, Humboldt Fund, MSD Capital, MSD Partners, Octave Group, and OMX Ventures, along with support from existing investors, including Avenir Growth Capital, OCV Partners, Shumway Capital, SIG, SymBiosis, TPTF, and Willett Advisors.
Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies
BioSpace, August 22, 2019
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced today the completion of a $53 million Series C financing. The financing comes from new investors including OCV Partners, Susquehanna International Group (SIG), Symbiosis LLC and the Trans-Pacific Technology Fund, as well as existing investors, including Avenir Growth Capital, Morgan Noble, Shumway Capital, and Willett Advisors.
Chris Shumway Gives UVA $25 Million to Train Bioscientists in Business
University of Virginia, September 25, 2018
The University of Virginia today announced a $25 million gift from The Chris and Carrie Shumway Foundation to fund an innovative new building and new bioscience/business program.
Elligo Health Research Raises $16M to Improve Access to Clinical Trials
Business Wire, March 20, 2018
Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, announced today $16 million in Series B funding led by Hatteras Venture Partners and Noro-Moseley Partners with participation from FS Healthcare LLC, Excelerate Health Ventures and all existing Series A investors including Shumway Capital.
Finch Therapeutics Group Inks $36M in Series B
VC News Daily, March 5, 2018
Privately held microbiome therapeutics company, announced today the successful close of an oversubscribed $36 million Series B financing.
Bond-Trader TruMid Sells Stake Valuing Company at $75 Million
Bloomberg, March 4, 2015
TruMid Financial LLC raised money from investors in a deal valuing the bond-trading startup at $75 million, according to President Ravi Singh. TruMid is among more than a dozen firms, including Bloomberg News parent Bloomberg LP, trying to help make it easier to trade debt in the $7.7 trillion U.S. corporate bond market. Like its competitors, TruMid is operating in a market reshaped by regulations following the 2008 financial crisis.
Chris Shumway Goes Long Moody’s at Ira Sohn Conference
Yahoo! News, May 5, 2014
Shares of Moody’s (NYSE: MCO) jump following comments from Chris Shumway at the Ira Sohn Conference. The founder and managing partner of Shumway Capital Partners LLC, Shumway was recognized as a Top 10 performing manager by Barron’s Magazine.